Sermorelin
CAS #: 86168-78-7
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Sermorelin Overview
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone (GHRH). It has been studied in controlled experimental settings for its role in the growth-hormone axis and associated secretory signaling.
History
Sermorelin was characterized as the shortest fully functional fragment of GHRH. Early research established its receptor activity, and later studies expanded into endocrine and systemic models examining growth-hormone regulation.
Sermorelin Structure
- CAS #:
- 86168-78-7
- Molecular Formula:
- C149H246N44O42S
- Molecular Weight:
- 3357.9 g/mol
- PubChem ID:
- 16132413
Research Findings
Sermorelin has been studied in endocrine and systemic models, with reports of activity in GHRH-receptor signaling, secretory pulse dynamics, and growth-hormone release within preclinical research settings.
Key Areas of Research:
- Endocrine: GHRH receptor, GH axis
- Secretory: pulse dynamics, GH release
- Cellular: receptor signaling, viability
- Systemic: pathway dynamics, resilience
References
- Synthesis & Characterization. Solid-phase peptide synthesis, purification, and analytical confirmation of identity and purity.
- Preclinical Research. Reported activity across structural, vascular, and systemic models in controlled experimental settings.
- Stability Studies. Lyophilized stability and reconstitution behavior under controlled cold-chain storage.
- Analytical Verification. Third-party HPLC and mass-spectrometry verification of mass, identity, and purity.
